NINE.V - Delta 9 Cannabis Inc.

TSXV - TSXV Delayed Price. Currency in CAD
1.0300
+0.0300 (+3.00%)
As of 3:59PM EDT. Market open.
Stock chart is not supported by your current browser
Previous Close1.0000
Open1.0500
Bid1.0300 x N/A
Ask1.0500 x N/A
Day's Range1.0300 - 1.1300
52 Week Range0.9200 - 1.7500
Volume68,729
Avg. Volume82,555
Market Cap89.362M
Beta (3Y Monthly)N/A
PE Ratio (TTM)19.07
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
All
News
Press Releases
  • Westleaf Signs One Year $4 Million White-Label Cannabis Derivative Product Sale Agreement with an Option to Increase to $16 Million
    CNW Group

    Westleaf Signs One Year $4 Million White-Label Cannabis Derivative Product Sale Agreement with an Option to Increase to $16 Million

    CALGARY , July 24, 2019 /CNW/ - Westleaf Inc. (the "Company" or "Westleaf") (WL.V) (WSLFF), is pleased to announce that its subsidiary, Westleaf Labs LP, has entered into a white labeling agreement with Delta 9 (NINE.V)(VRNDF) to supply approximately $4 million of cannabis derivative products from its large-scale extraction and manufacturing facility located in Calgary , known as The Plant. Under the terms of the agreement, the contract will begin on October 1 , subject to receipt of final license approval from Health Canada, and will carry an initial term of one year, whereby Delta 9 will be required to purchase a minimum of ~$4 million of various white labelled derivative products (such products are expected to include a mix of vape pens, gel caps, tincture oil, and edibles) with an option to increase such amount up to $16 million per year.

  • Delta 9 Signs One-Year White Label Cannabis Derivative Manufacturing Agreement with Westleaf
    CNW Group

    Delta 9 Signs One-Year White Label Cannabis Derivative Manufacturing Agreement with Westleaf

    WINNIPEG , July 24, 2019 /CNW/ - DELTA 9 CANNABIS INC. (TSXV:DN) (VRNDF) ("Delta 9" or the "Company") is pleased to announce that its subsidiary, Delta 9 Bio-Tech Inc., has entered into a one-year white labeling agreement with Westleaf Inc.("Westleaf") (WL.V) (WSLFF) to supply approximately $4 million of cannabis derivative products from Westleaf's large-scale extraction and manufacturing facility located in Calgary , known as The Plant. Under the terms of the agreement, the deliveries of cannabis derivative products will begin on October 1, 2019 subject to receipt of final license approval from Health Canada for The Plant, and will continue an initial term of one year. During this initial year, Delta 9 will be required to purchase a minimum of approximately $4 million of various white labeled cannabis derivative products (subject to regulation, such products are expected to include a mix of vape pens, gel caps, tincture oil, and edibles) with an option to increase such amount up to $16 million per year.

  • Delta 9 Announces Commencement of Trading of Debentures and Warrants and Change of Trading Symbol
    CNW Group

    Delta 9 Announces Commencement of Trading of Debentures and Warrants and Change of Trading Symbol

    WINNIPEG , July 24, 2019 /CNW/ - Delta 9 Cannabis Inc. ("Delta 9" or the "Company") (TSXV:DN) (VRNDF) is pleased to announce that the Company's 8.5% unsecured convertible debentures maturing July 17, 2022 (the "Convertible Debentures") and common share purchase warrants expiring July 17, 2022 (the "Warrants") that were issued pursuant to the Company's short form prospectus offering that closed on July 17, 2019 , will commence trading on the TSX Venture Exchange on the date hereof. The Convertible Debentures will trade under the symbol "DN.DB" and the Warrants will trade under the symbol "DN.WT.A". The Company also wishes to announce that the Company's trading symbol for its common shares has changed from "NINE" to "DN".

  • CNW Group

    TSX Venture Exchange Stock Maintenance Bulletins

    TSX Venture Exchange Stock Maintenance Bulletins

  • Delta 9 Announces Closing of $11.8 Million Public Offering of Convertible Debenture Units
    CNW Group

    Delta 9 Announces Closing of $11.8 Million Public Offering of Convertible Debenture Units

    WINNIPEG , July 17, 2019 /CNW/ - Delta 9 Cannabis Inc. ("Delta 9" or the "Company") (NINE.V) (VRNDF) is pleased to announce the closing (the "Closing") of its previously announced public offering (the "Offering") of convertible debenture units of the Company (the "Debenture Units") for aggregate gross proceeds of $11,800,000 . The Offering was led by Mackie Research Capital Corporation and Canaccord Genuity Corp. (together, the "Agents"). The net proceeds received by Delta 9 from the Offering will be used for capital expenditures related to the expansion of Delta 9's production facility, capital expenditures relating to new retail cannabis stores and for general corporate and working capital purposes.

  • CNW Group

    IIROC Trading Resumption - NINE

    IIROC Trading Resumption - NINE

  • GlobeNewswire

    Delta 9 Announces Minimum $10 Million Public Offering of 8.5% Convertible Debenture Units

    Delta 9 Cannabis Inc. (“Delta 9” or the “Company”) (NINE.V) (VRNDF) is pleased to report that its offering, previously announced on June 17, 2019 (the “Offering”), will be for an offering size of a minimum of $10,000,000 and up to $14,000,000. The Offering will be conducted on an agency basis for the issuance of a minimum of 10,000 convertible debenture units (each, a “Convertible Debenture Unit”) and up to 14,000 Convertible Debenture Units at a price of $1,000 per Convertible Debenture Unit. The Offering is being co-led by Mackie Research Capital Corporation, as sole bookrunner, and Canaccord Genuity Corp. as co-lead agents (collectively, the “Agents”).

  • GlobeNewswire

    Delta 9 Announces Public Offering of Convertible Debenture Units

    Delta 9 Cannabis Inc. (“Delta 9” or the “Company”) (NINE.V) (VRNDF) is pleased to announce that it has filed and been receipted for a preliminary short form prospectus (the “Preliminary Prospectus”) with the securities regulatory authorities in all provinces of Canada (except Québec) in connection with a proposed marketed public offering (the “Offering”) of convertible debenture units (each, a “Convertible Debenture Unit”) at a price of $1,000 per Convertible Debenture Unit. The Offering is being co- led by Mackie Research Capital Corporation, as sole bookrunner, and Canaccord Genuity Corp. as co-lead agents (collectively, the “Agents”). Delta 9 will grant the Agents an option (the “Over-Allotment Option”) to cover over-allotments and for market stabilization purposes, exercisable at any time up to 30 days subsequent to the closing of the Offering, to increase the size of the Offering by up to 15%.

  • CNW Group

    IIROC Trading Halt - NINE

    IIROC Trading Halt - NINE

  • CNW Group

    Delta 9 Reports Record Revenue for Q1 2019

    Delta 9 Reports Record Revenue for Q1 2019

  • CNW Group

    Delta 9 Reports Record Revenue for Year End 2018

    Delta 9 Reports Record Revenue for Year End 2018

  • CNW Group

    Delta 9 Provides Guidance for Fiscal 2018 Results, Anticipating Revenues of $7.6M to $8.4M

    Based on preliminary (unaudited) results, the Company anticipates revenues of between $7.6 million and $8.4 million for the twelve-month period ending December 31, 2018 , compared to $944,114 for the same period the prior year. Based on preliminary (unaudited) results, the Company anticipates revenues of between $5.3 million and $6.1 million for the three-month period ending December 31, 2018 , compared with $1,251,213 for the three-month period ending September 30, 2018 . Management believes that revenue growth and disciplined cost management will allow the Company to achieve positive cashflow in fiscal 2019.

  • CNW Group

    Delta 9 Announces Future Expansion Plans Including Increase of Production Capacity to 60,000 Kilograms by 2022

    WINNIPEG , Feb. 21, 2019 /CNW/ - DELTA 9 CANNABIS INC. (NINE.V) (VRNDF) ("Delta 9" or the "Company") is pleased to provide an update on its expansion plans. Highlights include that the Company intends to increase its annual cannabis production capacity to 60,000 kilograms per year by 2022 and the expansion of its retail store network to four stores by the end of the second quarter of, 2019. "Today we are pleased to provide our long-term vision to transform Delta 9's Winnipeg based production facilities into one of the largest cannabis production, processing, extraction and distribution centers in Canada " said CEO, John Arbuthnot .

  • CNW Group

    Delta 9 Closes sale of Calgary facility to Westleaf

    WINNIPEG , Feb. 1, 2019 /CNW/ - DELTA 9 CANNABIS INC. (NINE.V) (VRNDF) ("Delta 9" or the "Company") is pleased to announce that effective January 31, 2019 (the "Closing Date") it has closed the previously announced sale of its 50% interest in the Delta West extraction facility to Westleaf Inc. (WL.V) ("Westleaf"). Pursuant to the transaction, Westleaf has issued an aggregate of 5,600,000 common shares in the capital of Westleaf ("Westleaf Shares") to Delta 9 in consideration for the acquisition of Delta 9's 50% interest in the limited partnership that owns the Delta West extraction facility.

  • PR Newswire

    Delta 9 sells interest in Calgary facility to Westleaf for $14.95 Million of Westleaf Shares

    WINNIPEG, Jan. 28, 2019 /PRNewswire/ - DELTA 9 CANNABIS INC. (NINE.V) ("Delta 9" or the "Company") is pleased to announce that it has entered into a definitive agreement ("Definitive Agreement")  to sell its 50% interest in the Delta West extraction facility to Westleaf Inc. (WL.V) ("Westleaf"). Under the Definitive Agreement, Westleaf has agreed to issue an aggregate of 5,600,000 common shares in the capital of Westleaf ("Westleaf Shares") in consideration for the acquisition of Delta 9's 50% interest in the project (the "Purchase Price").

  • Westleaf Announces Acquisition of 50% Interest in the Delta West Extraction Facility from Delta 9
    CNW Group

    Westleaf Announces Acquisition of 50% Interest in the Delta West Extraction Facility from Delta 9

    CALGARY , Jan. 28, 2019 /CNW/ - Westleaf Inc. (WL.V) ("Westleaf"), is pleased to announce it has signed a definitive agreement ("Definitive Agreement") to acquire Delta 9 Cannabis Inc.'s (NINE.V) ("Delta 9") 50% interest in the Delta West extraction facility, bringing Westleaf's total ownership to 100%. Under the Definitive Agreement, Westleaf has agreed to issue an aggregate of 5,600,000 common shares in the capital of Westleaf ("Common Shares") in consideration for the acquisition of Delta 9's 50% interest in the project (the "Purchase Price").

  • PR Newswire

    Delta 9 Signs Master License Agreement with NanoSphere Health Sciences

    WINNIPEG, Jan. 24, 2019 /PRNewswire/ - DELTA 9 CANNABIS INC. (NINE.V) ("Delta 9" or the "Company") is pleased to announce it has signed a Master License Agreement (the "Agreement") with NanoSphere Health Sciences, LLC ("NSHS") and its Canadian subsidiary, NanoSphere Cannabis International Inc. ("NCI", and collectively with NSHS, "NanoSphere"). The Agreement provides Delta 9 with an exclusive license in Canada to manufacture and sell products made with Nanosphere's patented technology for the delivery of cannabinoids via nanoparticle technology (the "NanoSphere Delivery System of Cannabis").

  • Delta 9 Receives Conditional Approval for Cannabis Store in Brandon, Manitoba
    CNW Group

    Delta 9 Receives Conditional Approval for Cannabis Store in Brandon, Manitoba

    WINNIPEG , Dec. 7, 2018 /CNW/ - DELTA 9 CANNABIS INC. (NINE.V) (VRNDF) ("Delta 9" or the "Company") is pleased to announce it has received conditional approval from the Manitoba Government to open a new cannabis 'SuperStore' in Brandon, Manitoba . At 4,800 square feet in size, the cannabis outlet will be the largest in Manitoba and will include an onsite Cannabis Education Centre offering courses on cannabis use and safety for the general public. "There are many people who may be completely new to cannabis or may not have tried it for years or even decades," explained Delta 9 CEO John Arbuthnot .